| |
Company
Roster
|
|
Total
Insiders : |
16 |
|
|
|
Total
Direct Shares :
|
3,657,636 |
|
|
Total
Indirect Shares :
|
101,674 |
| |
%
Held by Insiders:
|
5.92% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Thibault Lance E |
CFO & Treasurer |
2002-03-18 |
5,859 |
2002-03-18 |
0 |
| Gulcher Jeffrey |
Chief Scientific Officer |
2003-12-29 |
371,200 |
2003-12-05 |
0 |
| Formela Jean Francois |
Director |
2003-09-09 |
0 |
2003-12-11 |
0 |
| Beery James |
Director |
2008-05-29 |
22,621 |
2005-07-27 |
0 |
| Armstrong J Neal |
Director |
2008-05-29 |
33,931 |
2005-07-27 |
0 |
| Mcguire Terrance |
Director |
2008-12-01 |
15,842 |
2008-12-01 |
101,674 |
| Collier Earl M Jr |
Director |
2008-12-05 |
32,000 |
2008-12-05 |
0 |
| Smarason Hannes |
EVP & Snr. Business Officer |
2003-11-03 |
319,904 |
2003-11-03 |
0 |
| Sigurdsson Tomas |
Officer |
2006-05-30 |
4,608 |
|
0 |
| Zharov Tanya |
Officer |
2007-05-11 |
85,000 |
|
0 |
| Nielsen Axel |
Officer |
2007-06-11 |
90,000 |
|
0 |
| Stefansson Kari |
President & CEO, Director |
2005-02-10 |
2,625,292 |
2003-12-22 |
0 |
| Sigurdsson Jakob O |
S.V.P., Corporate Development |
2008-09-16 |
379 |
|
0 |
| Hartman Daniel L |
Sr. V.P. Product Development |
2005-07-15 |
50,000 |
2005-07-15 |
0 |
| Gurney Mark |
Sr. VP Drug Discovery & Dvpmt |
2007-06-05 |
1,000 |
2007-06-05 |
0 |
| Hakonarson Hakon |
V.P., Clinical Studies |
2005-08-24 |
0 |
|
0 |
|
